Literature DB >> 27190089

Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans.

Karthigayan Gunalan1, Eugenia Lo2, Jessica B Hostetler3, Delenasaw Yewhalaw4, Jianbing Mu1, Daniel E Neafsey5, Guiyun Yan2, Louis H Miller6.   

Abstract

The ability of the malaria parasite Plasmodium vivax to invade erythrocytes is dependent on the expression of the Duffy blood group antigen on erythrocytes. Consequently, Africans who are null for the Duffy antigen are not susceptible to P. vivax infections. Recently, P. vivax infections in Duffy-null Africans have been documented, raising the possibility that P. vivax, a virulent pathogen in other parts of the world, may expand malarial disease in Africa. P. vivax binds the Duffy blood group antigen through its Duffy-binding protein 1 (DBP1). To determine if mutations in DBP1 resulted in the ability of P. vivax to bind Duffy-null erythrocytes, we analyzed P. vivax parasites obtained from two Duffy-null individuals living in Ethiopia where Duffy-null and -positive Africans live side-by-side. We determined that, although the DBP1s from these parasites contained unique sequences, they failed to bind Duffy-null erythrocytes, indicating that mutations in DBP1 did not account for the ability of P. vivax to infect Duffy-null Africans. However, an unusual DNA expansion of DBP1 (three and eight copies) in the two Duffy-null P. vivax infections suggests that an expansion of DBP1 may have been selected to allow low-affinity binding to another receptor on Duffy-null erythrocytes. Indeed, we show that Salvador (Sal) I P. vivax infects Squirrel monkeys independently of DBP1 binding to Squirrel monkey erythrocytes. We conclude that P. vivax Sal I and perhaps P. vivax in Duffy-null patients may have adapted to use new ligand-receptor pairs for invasion.

Entities:  

Keywords:  DNA expansion; Duffy blood group antigen; Duffy-binding protein; Plasmodium vivax

Mesh:

Substances:

Year:  2016        PMID: 27190089      PMCID: PMC4896682          DOI: 10.1073/pnas.1606113113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  A reticulocyte-binding protein complex of Plasmodium vivax merozoites.

Authors:  M R Galinski; C C Medina; P Ingravallo; J W Barnwell
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Cloning of the Plasmodium vivax Duffy receptor.

Authors:  X D Fang; D C Kaslow; J H Adams; L H Miller
Journal:  Mol Biochem Parasitol       Date:  1991-01       Impact factor: 1.759

3.  The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals.

Authors:  A Chaudhuri; J Polyakova; V Zbrzezna; A O Pogo
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

4.  Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand.

Authors:  C M Wilson; S K Volkman; S Thaithong; R K Martin; D E Kyle; W K Milhous; D F Wirth
Journal:  Mol Biochem Parasitol       Date:  1993-01       Impact factor: 1.759

5.  Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein.

Authors:  S P Wertheimer; J W Barnwell
Journal:  Exp Parasitol       Date:  1989-11       Impact factor: 2.011

6.  Natural selection mediated association of the Duffy (FY) gene polymorphisms with Plasmodium vivax malaria in India.

Authors:  Anita Chittoria; Sujata Mohanty; Yogesh Kumar Jaiswal; Aparup Das
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

7.  The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.

Authors:  C E Chitnis; A Chaudhuri; R Horuk; A O Pogo; L H Miller
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

8.  Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria.

Authors:  Bridget E Barber; Timothy William; Matthew J Grigg; Uma Parameswaran; Kim A Piera; Ric N Price; Tsin W Yeo; Nicholas M Anstey
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

9.  Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.

Authors:  Nicholas M Douglas; Gysje J Pontororing; Daniel A Lampah; Tsin W Yeo; Enny Kenangalem; Jeanne Rini Poespoprodjo; Anna P Ralph; Michael J Bangs; Paulus Sugiarto; Nicholas M Anstey; Ric N Price
Journal:  BMC Med       Date:  2014-11-18       Impact factor: 8.775

10.  Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.

Authors:  Rossarin Suwanarusk; Bruce Russell; Marina Chavchich; Ferryanto Chalfein; Enny Kenangalem; Varakorn Kosaisavee; Budi Prasetyorini; Kim A Piera; Marion Barends; Alan Brockman; Usa Lek-Uthai; Nicholas M Anstey; Emiliana Tjitra; François Nosten; Qin Cheng; Ric N Price
Journal:  PLoS One       Date:  2007-10-31       Impact factor: 3.240

View more
  38 in total

1.  Complex DNA structures trigger copy number variation across the Plasmodium falciparum genome.

Authors:  Adam C Huckaby; Claire S Granum; Maureen A Carey; Karol Szlachta; Basel Al-Barghouthi; Yuh-Hwa Wang; Jennifer L Guler
Journal:  Nucleic Acids Res       Date:  2019-02-28       Impact factor: 16.971

Review 2.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

Review 3.  A Way Forward for Culturing Plasmodium vivax.

Authors:  Karthigayan Gunalan; Emma H Rowley; Louis H Miller
Journal:  Trends Parasitol       Date:  2020-04-29

4.  Single-cell transcription analysis of Plasmodium vivax blood-stage parasites identifies stage- and species-specific profiles of expression.

Authors:  Juliana M Sà; Matthew V Cannon; Ramoncito L Caleon; Thomas E Wellems; David Serre
Journal:  PLoS Biol       Date:  2020-05-04       Impact factor: 8.029

5.  Basigin Interacts with Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 as a Second Erythrocyte Receptor to Promote Parasite Growth.

Authors:  Sumit Rathore; Sheena Dass; Divya Kandari; Inderjeet Kaur; Mayank Gupta; Yagya D Sharma
Journal:  J Biol Chem       Date:  2016-11-23       Impact factor: 5.157

Review 6.  Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

Authors:  Karthigayan Gunalan; Amadou Niangaly; Mahamadou A Thera; Ogobara K Doumbo; Louis H Miller
Journal:  Trends Parasitol       Date:  2018-03-09

Review 7.  Molecular interactions governing host-specificity of blood stage malaria parasites.

Authors:  Erik J Scully; Usheer Kanjee; Manoj T Duraisingh
Journal:  Curr Opin Microbiol       Date:  2017-10-31       Impact factor: 7.934

8.  Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity.

Authors:  Enna Dogra Gupta; Gaurav Anand; Hina Singh; Kritika Chaddha; Praveen K Bharti; Neeru Singh; Yagya Dutta Sharma; Deepak Gaur
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

9.  Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali.

Authors:  Amadou Niangaly; Drissa Coulibaly; Juliana M Sá; Matthew Adams; Mark A Travassos; Jennifer Ferrero; Matthew B Laurens; Abdoulaye K Kone; Mahamadou A Thera; Christopher V Plowe; Louis H Miller; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

10.  Plasmodium vivax Infections in Duffy-Negative Individuals in the Democratic Republic of the Congo.

Authors:  Nicholas F Brazeau; Amy N Whitesell; Stephanie M Doctor; Corinna Keeler; Melchior Kashamuka Mwandagalirwa; Antoinette K Tshefu; Joris L Likwela; Jonathan J Juliano; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.